Research, Education, and Outreach on Botanical Natural Products
Food and Drug Administration
Free. Verify your email, then we send one reminder only.
- Posted
- Jul 22, 2026
- Amount
- $5,100,000
- Closes
- Aug 21, 2026 (in 29 days)
Classification and identifiers
- Solicitation number
- RFA-FD-26-011
- Assistance listing (CFDA)
- 93.103
Amount
$5,100,000
Who can apply
Only the following applicant is eligible to apply for this single source funding: The University of Mississippi
About this opportunity
The purpose of this funding opportunity is to provide continued support to: (1) assist in the identification and development of a prioritized list of botanical ingredients based on safety concerns, trends and knowledge of botanical ingredients in foods, dietary supplements, and cosmetics marketed in the U.S.; (2) acquire, validate and characterize authenticated reference materials, including raw and processed plant materials and purified natural products of relevance to FDA for evaluation of safety; (3) exchange technical and scientific information, methods and reference material with FDA scientists and other stakeholders; (4) collaborate with FDA scientists in research areas of mutual interest; (5) coordinate scientific workshops, training and conferences on botanical topics of public hea...
Related opportunities
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Food and Drug AdministrationCloses Feb 2028Up to $600K
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)National Institutes of HealthCloses Nov 2026
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)National Institutes of HealthCloses Nov 2026Up to $350K
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)National Institutes of HealthCloses Nov 2026Up to $1.1M
- Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not AllowedFood and Drug AdministrationCloses Apr 2027Up to $300K
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)National Institutes of HealthCloses Jun 2027